187 related articles for article (PubMed ID: 32771225)
1. PLA2G6 variants associated with the number of affected alleles in Parkinson's disease in Japan.
Daida K; Nishioka K; Li Y; Yoshino H; Shimada T; Dougu N; Nakatsuji Y; Ohara S; Hashimoto T; Okiyama R; Yokochi F; Suzuki C; Tomiyama M; Kimura K; Ueda N; Tanaka F; Yamada H; Fujioka S; Tsuboi Y; Uozumi T; Takei T; Matsuzaki S; Shibasaki M; Kashihara K; Kurisaki R; Yamashita T; Fujita N; Hirata Y; Ii Y; Wada C; Eura N; Sugie K; Higuchi Y; Kojima F; Imai H; Noda K; Shimo Y; Funayama M; Hattori N
Neurobiol Aging; 2021 Jan; 97():147.e1-147.e9. PubMed ID: 32771225
[TBL] [Abstract][Full Text] [Related]
2. PLA2G6 variant in Parkinson's disease.
Tomiyama H; Yoshino H; Ogaki K; Li L; Yamashita C; Li Y; Funayama M; Sasaki R; Kokubo Y; Kuzuhara S; Hattori N
J Hum Genet; 2011 May; 56(5):401-3. PubMed ID: 21368765
[TBL] [Abstract][Full Text] [Related]
3. The identified clinical features of Parkinson's disease in homo-, heterozygous and digenic variants of PINK1.
Hayashida A; Li Y; Yoshino H; Daida K; Ikeda A; Ogaki K; Fuse A; Mori A; Takanashi M; Nakahara T; Yoritaka A; Tomizawa Y; Furukawa Y; Kanai K; Nakayama Y; Ito H; Ogino M; Hattori Y; Hattori T; Ichinose Y; Takiyama Y; Saito T; Kimura T; Aizawa H; Shoji H; Mizuno Y; Matsushita T; Sato M; Sekijima Y; Morita M; Iwasaki A; Kusaka H; Tada M; Tanaka F; Sakiyama Y; Fujimoto T; Nagara Y; Kashihara K; Todo H; Nakao K; Tsuruta K; Yoshikawa M; Hara H; Yokote H; Murase N; Nakamagoe K; Tamaoka A; Takamiya M; Morimoto N; Nokura K; Kako T; Funayama M; Nishioka K; Hattori N
Neurobiol Aging; 2021 Jan; 97():146.e1-146.e13. PubMed ID: 32713623
[TBL] [Abstract][Full Text] [Related]
4. Association of rare heterozygous PLA2G6 variants with the risk of Parkinson's disease.
Liu H; Wang Y; Pan H; Xu K; Jiang L; Zhao Y; Xu Q; Sun Q; Tan J; Yan X; Li J; Tang B; Guo J
Neurobiol Aging; 2021 May; 101():297.e5-297.e8. PubMed ID: 33279242
[TBL] [Abstract][Full Text] [Related]
5. Genetic analysis of ATP13A2, PLA2G6 and FBXO7 in a cohort of Chinese patients with early-onset Parkinson's disease.
Shen T; Pu J; Lai HY; Xu L; Si X; Yan Y; Jiang Y; Zhang B
Sci Rep; 2018 Sep; 8(1):14028. PubMed ID: 30232368
[TBL] [Abstract][Full Text] [Related]
6. Four novel rare mutations of PLA2G6 in Chinese population with Parkinson's disease.
Gui YX; Xu ZP; Wen-Lv ; Liu HM; Zhao JJ; Hu XY
Parkinsonism Relat Disord; 2013 Jan; 19(1):21-6. PubMed ID: 23182313
[TBL] [Abstract][Full Text] [Related]
7. PLA2G6 mutations in PARK14-linked young-onset parkinsonism and sporadic Parkinson's disease.
Lu CS; Lai SC; Wu RM; Weng YH; Huang CL; Chen RS; Chang HC; Wu-Chou YH; Yeh TH
Am J Med Genet B Neuropsychiatr Genet; 2012 Mar; 159B(2):183-91. PubMed ID: 22213678
[TBL] [Abstract][Full Text] [Related]
8. Genotype-phenotype correlations of adult-onset PLA2G6-associated Neurodegeneration: case series and literature review.
Chu YT; Lin HY; Chen PL; Lin CH
BMC Neurol; 2020 Mar; 20(1):101. PubMed ID: 32183746
[TBL] [Abstract][Full Text] [Related]
9. The PLA2G6 gene in early-onset Parkinson's disease.
Kauther KM; Höft C; Rissling I; Oertel WH; Möller JC
Mov Disord; 2011 Nov; 26(13):2415-7. PubMed ID: 21812034
[TBL] [Abstract][Full Text] [Related]
10. Association between PLA2G6 gene polymorphisms and Parkinson's disease in the Chinese Han population.
Lv Z; Guo J; Sun Q; Li K; Yu R; Tian J; Yan X; Tang B
Parkinsonism Relat Disord; 2012 Jun; 18(5):641-4. PubMed ID: 22459563
[TBL] [Abstract][Full Text] [Related]
11. GCH1 variants contribute to the risk and earlier age-at-onset of Parkinson's disease: a two-cohort case-control study.
Pan HX; Zhao YW; Mei JP; Fang ZH; Wang Y; Zhou X; Zhou YJ; Zhang R; Zhang KL; Jiang L; Zeng Q; He Y; Wang Z; Liu ZH; Xu Q; Sun QY; Yang Y; Hu YC; Chen YS; Du J; Lei LF; Zhang HN; Wang CY; Yan XX; Shen L; Jiang H; Tan JQ; Li JC; Tang BS; Guo JF
Transl Neurodegener; 2020 Aug; 9(1):31. PubMed ID: 32746945
[TBL] [Abstract][Full Text] [Related]
12. Comprehensive LRRK2 and GBA screening in Portuguese patients with Parkinson's disease: identification of a new family with the LRRK2 p.Arg1441His mutation and novel missense variants.
Zhang L; Quadri M; Guedes LC; Coelho M; Valadas A; Mestre T; Lobo PP; Rosa MM; Simons E; Oostra BA; Ferreira JJ; Bonifati V
Parkinsonism Relat Disord; 2013 Oct; 19(10):897-900. PubMed ID: 23726462
[TBL] [Abstract][Full Text] [Related]
13. Utility and implications of exome sequencing in early-onset Parkinson's disease.
Trinh J; Lohmann K; Baumann H; Balck A; Borsche M; Brüggemann N; Dure L; Dean M; Volkmann J; Tunc S; Prasuhn J; Pawlack H; Imhoff S; Lill CM; Kasten M; Bauer P; Rolfs A; ; Klein C
Mov Disord; 2019 Jan; 34(1):133-137. PubMed ID: 30537300
[TBL] [Abstract][Full Text] [Related]
14. PLA2G6 accumulates in Lewy bodies in PARK14 and idiopathic Parkinson's disease.
Miki Y; Tanji K; Mori F; Kakita A; Takahashi H; Wakabayashi K
Neurosci Lett; 2017 Apr; 645():40-45. PubMed ID: 28213071
[TBL] [Abstract][Full Text] [Related]
15. Novel deep intronic mutation in PLA2G6 causing early-onset Parkinson's disease with brain iron accumulation through pseudo-exon activation.
Cavestro C; Panteghini C; Reale C; Nasca A; Fenu S; Salsano E; Chiapparini L; Garavaglia B; Pareyson D; Di Meo I; Tiranti V
Neurogenetics; 2021 Oct; 22(4):347-351. PubMed ID: 34387792
[TBL] [Abstract][Full Text] [Related]
16. Identification of a novel mutation in PLA2G6 gene and phenotypic heterogeneity analysis of PLA2G6-related neurodegeneration.
Ji Y; Li Y; Shi C; Gao Y; Yang J; Liang D; Yang Z; Xu Y
Parkinsonism Relat Disord; 2019 Aug; 65():159-164. PubMed ID: 31196701
[TBL] [Abstract][Full Text] [Related]
17. Phenotypic spectrum of patients with PLA2G6 mutation and PARK14-linked parkinsonism.
Yoshino H; Tomiyama H; Tachibana N; Ogaki K; Li Y; Funayama M; Hashimoto T; Takashima S; Hattori N
Neurology; 2010 Oct; 75(15):1356-61. PubMed ID: 20938027
[TBL] [Abstract][Full Text] [Related]
18. PARK14 (D331Y) PLA2G6 Causes Early-Onset Degeneration of Substantia Nigra Dopaminergic Neurons by Inducing Mitochondrial Dysfunction, ER Stress, Mitophagy Impairment and Transcriptional Dysregulation in a Knockin Mouse Model.
Chiu CC; Lu CS; Weng YH; Chen YL; Huang YZ; Chen RS; Cheng YC; Huang YC; Liu YC; Lai SC; Lin KJ; Lin YW; Chen YJ; Chen CL; Yeh TH; Wang HL
Mol Neurobiol; 2019 Jun; 56(6):3835-3853. PubMed ID: 30088174
[TBL] [Abstract][Full Text] [Related]
19. Association between PLA2G6 gene polymorphism for calcium-independent phospholipase A2 and nicotine dependence among males with schizophrenia.
Nadalin S; Rebić J; Šendula Jengić V; Peitl V; Karlović D; Buretić-Tomljanović A
Prostaglandins Leukot Essent Fatty Acids; 2019 Sep; 148():9-15. PubMed ID: 31492433
[TBL] [Abstract][Full Text] [Related]
20. Genotype-phenotype correlation of Parkinson's disease with PRKN variants.
Yoshino H; Li Y; Nishioka K; Daida K; Hayashida A; Ishiguro Y; Yamada D; Izawa N; Nishi K; Nishikawa N; Oyama G; Hatano T; Nakamura S; Yoritaka A; Motoi Y; Funayama M; Hattori N;
Neurobiol Aging; 2022 Jun; 114():117-128. PubMed ID: 35123805
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
